Cargando…

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment

Accumulating evidence supports an association between depression and inflammatory processes, a connection that seems to be bidirectional. Clinical trials have indicated antidepressant treatment effects for anti-inflammatory agents, both as add-on treatment and as monotherapy. In particular, nonstero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köhler, Ole, Krogh, Jesper, Mors, Ole, Benros, Michael Eriksen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050394/ https://www.ncbi.nlm.nih.gov/pubmed/27640518 http://dx.doi.org/10.2174/1570159X14666151208113700

Ejemplares similares

Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2018)

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study
por: Horsdal, Henriette Thisted, et al.
Publicado: (2017)

Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2019)

T11. CEREBROSPINAL FLUID (CSF) MARKERS OF INFLAMMATION AND INFECTIONS IN SCHIZOPHRENIA AND AFFECTIVE DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Orlovska, Sonja, et al.
Publicado: (2018)

Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes
por: Köhler, Ole, et al.
Publicado: (2015)

F137. INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AS A RISK FACTOR FOR MENTAL DISORDERS AND COGNITIVE IMPAIRMENT: A NATIONWIDE REGISTER-BASED STUDY
por: Pedersen, Emilie, et al.
Publicado: (2018)

Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
por: Futtrup, Jesper, et al.
Publicado: (2020)

The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies
por: Benrós, Michael Eriksen, et al.
Publicado: (2015)

Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders
por: Orbe, Elif Bayram, et al.
Publicado: (2023)

Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia
por: Köhler, Ole, et al.
Publicado: (2016)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)

Genetic and psychosocial influence on the association between early childhood infections and later psychiatric disorders
por: Debost, Jean‐Christophe Philippe Goldtsche, et al.
Publicado: (2022)

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
por: Vindegaard, Nina, et al.
Publicado: (2020)

Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity
por: Speyer, Helene, et al.
Publicado: (2015)

Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial
por: Jakobsen, Ane Storch, et al.
Publicado: (2017)

Autoimmune Diseases and Psychotic Disorders
por: Jeppesen, Rose, et al.
Publicado: (2019)

Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2022)

Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors
por: Krebs, Morten Dybdahl, et al.
Publicado: (2021)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?
por: Zhang, Yuqing, et al.
Publicado: (2021)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2022)

S46. THE VALIDITY AND SENSITIVITY OF PANSS-6 IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ostergaard, Soren Dinesen, et al.
Publicado: (2018)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Are depressive disorders caused by psychosocial stressors at work? A systematic review with metaanalysis
por: Mikkelsen, Sigurd, et al.
Publicado: (2021)

Anti-inflammatory Effects of Alcohol Are Associated with JNK-STAT3 Downregulation in an In Vitro Inflammation Model in HepG2 Cells
por: Mörs, Katharina, et al.
Publicado: (2021)

Comparisons of 25 cerebrospinal fluid cytokines in a case–control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2023)

Deep learning–based integration of genetics with registry data for stratification of schizophrenia and depression
por: Allesøe, Rosa Lundbye, et al.
Publicado: (2022)

Inflammation as the Potential Basis in Depression
por: Maeng, Sung Ho, et al.
Publicado: (2019)

Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
por: Costiniuk, Cecilia T., et al.
Publicado: (2020)

Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)

Inflammation‐Controlled Anti‐Inflammatory Hydrogels
por: Helmecke, Tina, et al.
Publicado: (2022)

The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
por: Schnur, Sabrina, et al.
Publicado: (2023)

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
por: Tahamtan, Alireza, et al.
Publicado: (2018)

Network perturbation-based biomarkers of depression and treatment response
por: Müller-Dahlhaus, Florian, et al.
Publicado: (2023)

Potential Anti-Inflammatory Effect of Rosmarinus officinalis in Preclinical In Vivo Models of Inflammation
por: Gonçalves, Catarina, et al.
Publicado: (2022)

Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs
por: Figueiredo, Clara Salles, et al.
Publicado: (2023)

The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression
por: Strawbridge, Rebecca, et al.
Publicado: (2021)

Aldosterone exerts anti-inflammatory effects on LPS stimulated microglia
por: Bast, Björn-Ole, et al.
Publicado: (2018)

Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes—potential differences by diabetes type and depression scores
por: Herder, Christian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nhenk9kftktdi9qj97n6adaur3